Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Research programme: biosimilars - American Biosources

Next Previous
Drug Profile

Research programme: biosimilars - American Biosources

Latest Information Update: 28 Jun 2019

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator American Biosources
  • Class Blood coagulation factors; Blood proteins; Colony-stimulating factors; Hormones; Interferons; Interleukins; Monoclonal antibodies; Vaccines
  • Mechanism of Action Antibody-dependent cell cytotoxicity; Colony stimulating factor stimulants; Factor IX stimulants; Factor VIII stimulants; Glucosylceramidase stimulants; Haematopoietic cell growth factor stimulants; Hormone stimulants; Immunostimulants; Immunosuppressants; Interferon alpha stimulants; Interferon beta stimulants; Plasminogen activators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • No development reported Anaemia; Endocrine disorders; Gaucher's disease; Haematological disorders; Hepatitis B; Leukaemia; Multiple sclerosis; Neutropenia; Rheumatoid arthritis

Most Recent Events

  • 28 Jun 2019 No recent reports of development identified for research development in Anaemia in USA
  • 28 Jun 2019 No recent reports of development identified for research development in Endocrine-disorders in USA
  • 28 Jun 2019 No recent reports of development identified for research development in Gaucher's-disease in USA
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top